查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494715

加替沙星市场：按给药途径、剂型、适应症、销售管道划分 - 全球预测 2024-2030

Gatifloxacin Market by Route of Administration (Intravenous, Ophthalmic, Oral), Form (Solution, Tablet), Indication, Sales Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年加替沙星市场规模为31,549万美元，2024年达33,132万美元，预计2030年将达44,046万美元，复合年增长率为4.88%。

加替沙星是一种属于Fluoroquinolones家族的抗生素。它旨在透过抑制细菌 DNA 复製、修復和转录所需的酵素来对抗细菌感染。这种作用可以抑制细菌生长并治疗感染疾病。加替沙星通常用于治疗结膜炎、红眼症和呼吸道感染疾病等感染疾病。由于加替沙星具有广泛的抗菌特性，对加替沙星的需求不断增加，并且支持医疗基础设施改革以改善加替沙星等抗生素的获取，这进一步推动了市场成长。然而，由于安全问题、仿冒品盛行以及生产问题而导致的产品召回问题不断增加，正在阻碍市场成长。然而，加替沙星生产技术的不断进步以及製药公司与学术和研究机构之间不断增加的合作伙伴关係为加替沙星市场提供了潜在的成长潜力。

主要市场统计
基准年[2023] 31549万美元
预测年份 [2024] 33132万美元
预测年份 [2030] 44046万美元
复合年增长率（%） 4.88%

区域洞察

在美洲，在先进的医疗保健系统和持续的抗生素功效和安全性研究的支持下，美国和加拿大的加替沙星保持强劲增长。加替沙星市场也受到鼓励谨慎使用抗生素以防止抗药性细菌增加的法律规范的影响。投资趋势包括组合药物的开发和新治疗领域的开拓。欧洲、中东和非洲地区的加替沙星市场受到经济状况、医疗保健系统和监管标准差异的影响。欧盟国家正专注于严格控制和创新研究，而中东和非洲国家正在努力改善医疗保健服务并应对流行的感染疾病。治疗的重点是加强医疗保健设施并整合全球卫生倡议，以增加包括加替沙星在内的有效治疗方法的可用性。由于亚太地区人口众多且医疗保健需求不断增长，加替沙星的发展呈现成长态势。该地区多样化的经济状况意味着已开发国家专注于创新和改善现有治疗方法，而新兴市场则优先考虑准入和负担能力。投资主要用于扩大医疗基础设施和新药应用研究。

FPNV定位矩阵

FPNV 定位矩阵对于评估加替沙星市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对加替沙星市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该领域竞争性质的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对加替沙星市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 广谱抗菌特性增加了加替沙星的需求
      • 医疗基础设施的支持性改革以增加抗生素的获取
    • 抑制因素
      • 因安全问题而召回产品
    • 机会
      • 加替沙星生产技术不断进步
      • 製药公司与学术或研究机构之间的合作关係
    • 任务
      • 仿冒品的盛行与製造问题
  • 市场区隔分析
    • 形式：加替沙星的表格形式因其易于给药而越来越受欢迎。
    • 适应症：增加加替沙星在眼部感染疾病治疗的使用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 加替沙星市场：依给药途径

  • 静脉
  • 眼科
  • 口服

第七章 加替沙星市场：依形式

  • 解决方案
  • 药片

第八章 加替沙星市场适应症

  • 眼部感染疾病
  • 呼吸道感染疾病
  • 鼻窦感染疾病
  • 皮肤感染疾病

第九章加替沙星市场：依销售管道

  • 医院药房
  • 网路商店
  • 零售药房

第10章 美洲加替沙星市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区加替沙星市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲加替沙星市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • 随着 eThekwini 地区结膜炎病例增加而发布的公共卫生建议
    • 山德士凭藉着六种产品的独家经销权加强其在美国市场的影响力
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-5D693B46BAB9

[196 Pages Report] The Gatifloxacin Market size was estimated at USD 315.49 million in 2023 and expected to reach USD 331.32 million in 2024, at a CAGR 4.88% to reach USD 440.46 million by 2030.

Gatifloxacin is an antibiotic belonging to the fluoroquinolone class of medications. It is designed to combat bacterial infections by inhibiting the enzymes necessary for bacterial DNA replication, repair, and transcription. This action helps to eliminate bacterial growth and treat infections. Gatifloxacin is commonly used to treat infections, including conjunctivitis, pink eye, and respiratory tract infections. Increasing demand for gatifloxacin due to broad-spectrum antibacterial properties and supportive reforms in healthcare infrastructure enhancing access to antibiotics such as gatifloxacin, further propelling the market growth. However, rising product recall issues due to safety concerns the, the prevalence of counterfeit products, and production issues hinder the market growth. Nevertheless, continuous advancements in the production technologies of gatifloxacin and rising partnerships between pharmaceutical companies and academic or research institutions create potential growth avenues for the gatifloxacin market.

KEY MARKET STATISTICS
Base Year [2023] USD 315.49 million
Estimated Year [2024] USD 331.32 million
Forecast Year [2030] USD 440.46 million
CAGR (%) 4.88%

Regional Insights

In the Americas, the U.S. and Canada maintain robust growth in gatifloxacin, supported by advanced healthcare systems and ongoing antibiotic efficacy and safety research. The gatifloxacin market is also influenced by regulatory frameworks that promote the careful use of antibiotics to prevent resistance buildup. Investment trends include the development of combination drugs and the exploration of new therapeutic areas. In the EMEA region, the gatifloxacin market is influenced by differing economic conditions, healthcare systems, and regulatory standards. EU countries emphasize stringent control and innovative research, while the Middle East and Africa are working towards improving healthcare access and handling prevalent infections. Investments focus on enhancing healthcare facilities and integrating global health initiatives to increase the availability of effective treatments, including gatifloxacin. The APAC region shows an evolving growth of gatifloxacin driven by large populations and rising healthcare needs. The region's diverse economic landscapes mean that while advanced economies focus on innovation and improving existing treatments, emerging markets prioritize access and affordability. Investments are heavily directed towards expanding healthcare infrastructure and researching new drug applications.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Gatifloxacin Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing demand for gatifloxacin due to broad-spectrum antibacterial properties
      • Supportive reforms in healthcare infrastructure enhancing access to antibiotics
    • Market Restraints
      • Product recalls due to safety concerns
    • Market Opportunities
      • Continuous advancements in production technologies of gatifloxacin
      • Partnerships between pharmaceutical companies and academic or research institutions
    • Market Challenges
      • Prevalence of counterfeit products and production issues
  • Market Segmentation Analysis
    • Form: Burgeoning preference for the table form of gatifloxacin due to the easy administration
    • Indication: Proliferating usage of gatifloxacin to treat eye infections
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Gatifloxacin Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Gatifloxacin Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Escalation of Pink Eye Cases in eThekwini Prompts Public Health Advisory

eThekwini witnessed a noteworthy surge in cases of pink eye (conjunctivitis), prompting health authorities to issue alerts and advice to the public. Initially identified in several educational institutions, the outbreak has affected numerous individuals, leading to concerns about wider community spread. The KwaZulu-Natal Department of Health confirmed the incidents, urging the public to adhere to hygiene practices such as frequent hand washing and avoiding contact with those infected. Measures are being implemented to contain the outbreak and prevent further transmission, with health officials closely monitoring the situation. [Published On: 2024-03-02]

Sandoz Enhances U.S. Market Presence through Exclusive Commercialization Rights for Six Products

Sandoz, a global entity in the generics and biosimilars industry, secured an exclusive agreement with Adalvo to commercialize six pivotal healthcare products in the United States, focusing on anti-infectives, oncology, and pulmonary treatments. This initiative is set to bolster patient access to essential, cost-effective medications and drive sustainability in global healthcare systems. [Published On: 2023-05-04]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Gatifloxacin Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Gatifloxacin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adore Pharmaceuticals Pvt. Ltd., Allergan, Inc., Apotex Inc., Bristol-Myers Squibb Company, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Knox Life Sciences, Lupin Pharmaceuticals, Inc., Mylan N.V., Novartis AG, Roche Holding AG, and Sandoz International GmbH.

Market Segmentation & Coverage

This research report categorizes the Gatifloxacin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Intravenous
    • Ophthalmic
    • Oral
  • Form
    • Solution
    • Tablet
  • Indication
    • Eye Infections
    • Respiratory Infections
    • Sinus Infections
    • Skin Infections
  • Sales Channel
    • Hospital Pharmacy
    • Online Stores
    • Retail Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for gatifloxacin due to broad-spectrum antibacterial properties
      • 5.1.1.2. Supportive reforms in healthcare infrastructure enhancing access to antibiotics
    • 5.1.2. Restraints
      • 5.1.2.1. Product recalls due to safety concerns
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous advancements in production technologies of gatifloxacin
      • 5.1.3.2. Partnerships between pharmaceutical companies and academic or research institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Prevalence of counterfeit products and production issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Form: Burgeoning preference for the table form of gatifloxacin due to the easy administration
    • 5.2.2. Indication: Proliferating usage of gatifloxacin to treat eye infections
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Gatifloxacin Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intravenous
  • 6.3. Ophthalmic
  • 6.4. Oral

7. Gatifloxacin Market, by Form

  • 7.1. Introduction
  • 7.2. Solution
  • 7.3. Tablet

8. Gatifloxacin Market, by Indication

  • 8.1. Introduction
  • 8.2. Eye Infections
  • 8.3. Respiratory Infections
  • 8.4. Sinus Infections
  • 8.5. Skin Infections

9. Gatifloxacin Market, by Sales Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacy
  • 9.3. Online Stores
  • 9.4. Retail Pharmacy

10. Americas Gatifloxacin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Gatifloxacin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Gatifloxacin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Escalation of Pink Eye Cases in eThekwini Prompts Public Health Advisory
    • 13.3.2. Sandoz Enhances U.S. Market Presence through Exclusive Commercialization Rights for Six Products
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. GATIFLOXACIN MARKET RESEARCH PROCESS
  • FIGURE 2. GATIFLOXACIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GATIFLOXACIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GATIFLOXACIN MARKET DYNAMICS
  • FIGURE 7. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GATIFLOXACIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL GATIFLOXACIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. GATIFLOXACIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. GATIFLOXACIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GATIFLOXACIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GATIFLOXACIN MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL GATIFLOXACIN MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL GATIFLOXACIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL GATIFLOXACIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL GATIFLOXACIN MARKET SIZE, BY SOLUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL GATIFLOXACIN MARKET SIZE, BY SOLUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL GATIFLOXACIN MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL GATIFLOXACIN MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL GATIFLOXACIN MARKET SIZE, BY EYE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL GATIFLOXACIN MARKET SIZE, BY EYE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL GATIFLOXACIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL GATIFLOXACIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL GATIFLOXACIN MARKET SIZE, BY SINUS INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL GATIFLOXACIN MARKET SIZE, BY SINUS INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL GATIFLOXACIN MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL GATIFLOXACIN MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL GATIFLOXACIN MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL GATIFLOXACIN MARKET SIZE, BY ONLINE STORES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SWEDEN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 342. SWEDEN GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 350. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 353. TURKEY GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 354. TURKEY GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 357. TURKEY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 358. TURKEY GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 366. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY SALES CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 368. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 369. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 370. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 371. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 372. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 373. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY SALE